Publications by authors named "Defeng Tian"

Claim this Profile
A
Altered functional connectivity within and between resting-state networks in ulcerative colitis.
Yanjun Ren, Kaizhong Xue, Huijuan Xu, Lijie Hao, Quchuan Zhao, Tianyu Chi, Defeng Tian

Brain Imaging Behav· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pons as an optimal background reference region for spinal F-FET PET/MRI evaluation.
Jing Huang, Jiyuan Wang, Bixiao Cui, Hongwei Yang, Defeng Tian

EJNMMI Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion Tensor Imaging Identifies Cervical Spondylosis, Myelitis, and Spinal Cord Tumors.
Jiyuan Wang, Jing Huang, Bixiao Cui, Hongwei Yang, Defeng Tian

Diagnostics (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in Mice.
Erik B Faber, Nan Wang, Kristen John, Luxin Sun, Henry L Wong, Defeng Tian

J Med Chem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population genetic structure of highlights the necessity and feasibility of hierarchical analysis for a highly differentiated species.
Chaoqiang Zhang, Yiwei Tang, Defeng Tian, Yanyan Huang, Guanghui Yang

Front Plant Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of land use change on population survival of three wild rice species in China since 2001.
Hao Chen, Shanshan Dong, Zhizhou He, Yuhong Chen, Defeng Tian

Front Plant Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of Q.Clear reconstruction on quantification and spatial resolution of 18F-FDG PET in simultaneous PET/MR.
Defeng Tian, Hongwei Yang, Yan Li, Bixiao Cui, Jie Lu

EJNMMI Phys· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FBNTI, a DOR-Selective Antagonist That Allosterically Activates MOR within a MOR-DOR Heteromer.
Eyup Akgün, Mary M Lunzer, Defeng Tian, Michael Ansonoff, John Pintar

Biochemistry· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperativity Between Orthosteric Inhibitors and Allosteric Inhibitor 8-Anilino-1-Naphthalene Sulfonic Acid (ANS) in Cyclin-Dependent Kinase 2.
Erik B Faber, Defeng Tian, David Burban, Nicholas M Levinson, Jon E Hawkinson

ACS Chem Biol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Adenine Nucleotide Translocase (ANT) Modulators Identified by High-Throughput Screening of Transgenic Yeast.
Yujian Zhang, Defeng Tian, Hironori Matsuyama, Takashi Hamazaki, Takayuki Shiratsuchi

J Biomol Screen· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput screening for growth inhibitors using a yeast model of familial paraganglioma.
Irina Bancos, John Paul Bida, Defeng Tian, Mary Bundrick, Kristen John

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues.
Sonia G Das, Jignesh M Doshi, Defeng Tian, Sadiya N Addo, Balasubramanian Srinivasan

J Med Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth.
Liangyou Wang, Daniel T Sloper, Sadiya N Addo, Defeng Tian, Joel W Slaton

Cancer Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethyl-2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H- chromene-3-carboxylate (HA 14-1), a prototype small-molecule antagonist against antiapoptotic Bcl-2 proteins, decomposes to generate reactive oxygen species that induce apoptosis.
Jignesh M Doshi, Defeng Tian, Chengguo Xing

Mol Pharm· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell.
Defeng Tian, Sonia G Das, Jignesh M Doshi, Jun Peng, Jialing Lin

Cancer Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
Jignesh M Doshi, Defeng Tian, Chengguo Xing

J Med Chem· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a new high-throughput screening model for human high density lipoprotein receptor (CLA-1) agonists.
De-Feng Tian, Bin Hong, Shu-Yi Si

Biomed Environ Sci· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis